CXXI — C21 Investments Share Price
0.000.00%
Last trade - 00:00- CA$22.40m
- CA$24.21m
- $28.29m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.53 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.59 | ||
| EV to EBITDA | 13.74 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.49% | ||
| Return on Equity | -14.4% | ||
| Operating Margin | -2.26% | ||
Financial Summary
| Year End 31st Jan | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 37.71 | 33.47 | 32.98 | 28.89 | 28.29 | n/a | n/a | 61.36% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -84.38 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
C21 Investments Inc. is a Canada-based vertically integrated cannabis company that cultivates, processes and distributes cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets with multi-market branded consumer packaged goods (CPG). The Company holds licenses in Nevada spanning the entire cannabis supply chain. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of tetrahydrocannabinol (THC) and cannabidiol (CBD) products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. Its extraction processing supports branded CPG in both captive retail and wholesale channels. It operates approximately three dispensaries.
Directors
- D. Bruce Macdonald NEC
- Sonny Newman PRE
- Michael Kidd CFO
- Skyler Pinnick CMO
- Russ Rotondi GCN
- Todd Harrison DRC
- Leonard Werden DRC
- Last Annual
- January 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- January 15th, 1987
- Public Since
- June 18th, 2018
- No. of Employees
- 160
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 117,887,314
- Address
- Suite 1900-855 West Georgia Street, VANCOUVER, V6C 3H4
- Web
- https://www.cxxi.ca/
- Phone
- +1 6043368613
- Auditors
- Davidson & Company LLP
Upcoming Events for CXXI
Q4 2025 C21 Investments Inc Earnings Release
Q1 2026 C21 Investments Inc Earnings Release
Similar to CXXI
Blueberries Medical
Canadian Securities Exchange
Green Thumb Industries
Canadian Securities Exchange
IM Cannabis
Canadian Securities Exchange
Nass Valley Gateway
Canadian Securities Exchange
Planet 13 Holdings
Canadian Securities Exchange
FAQ
What is the C21 Investments share price?
As of Today at 19:45 UTC, shares in C21 Investments are trading at CA$0.19. This share price information is delayed by 15 minutes.
How has the C21 Investments share price performed this year?
Shares in C21 Investments last closed at CA$0.19 and the price had moved by -59.14% over the past 365 days. In terms of relative price strength the C21 Investments share price has underperformed the Toronto Stock Exchange 300 Composite Index by -63.17% over the past year.
What are the analyst and broker recommendations for C21 Investments?
There is no consensus recommendation for this security.
Find out moreWhat is the C21 Investments dividend yield?
C21 Investments does not currently pay a dividend.
Does C21 Investments pay a dividend?
C21 Investments does not currently pay a dividend.
When does C21 Investments next pay dividends?
C21 Investments does not currently pay a dividend.
How do I buy C21 Investments shares?
To buy shares in C21 Investments you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of C21 Investments?
As of the previous close price of CA$0.19, shares in C21 Investments had a market capitalisation of CA$22.40m.
Where are C21 Investments shares listed?
Here are the trading details for C21 Investments:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: CXXI
What kind of share is C21 Investments?
Based on an overall assessment of its quality, value and momentum C21 Investments is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a C21 Investments share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the C21 Investments share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like C21 Investments. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -39.32%.
As of the last closing price of CA$0.19, shares in C21 Investments were trading -34.45% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the C21 Investments PE Ratio?
The C21 Investments PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.19.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of C21 Investments?
C21 Investments' management team is headed by:
- D. Bruce Macdonald - NEC
- Sonny Newman - PRE
- Michael Kidd - CFO
- Skyler Pinnick - CMO
- Russ Rotondi - GCN
- Todd Harrison - DRC
- Leonard Werden - DRC